1. Home
  2. PNTG vs BCTXW Comparison

PNTG vs BCTXW Comparison

Compare PNTG & BCTXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNTG
  • BCTXW
  • Stock Information
  • Founded
  • PNTG 2019
  • BCTXW N/A
  • Country
  • PNTG United States
  • BCTXW Canada
  • Employees
  • PNTG N/A
  • BCTXW 18
  • Industry
  • PNTG Medical/Nursing Services
  • BCTXW Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNTG Health Care
  • BCTXW Health Care
  • Exchange
  • PNTG Nasdaq
  • BCTXW Nasdaq
  • Market Cap
  • PNTG 1.1B
  • BCTXW N/A
  • IPO Year
  • PNTG N/A
  • BCTXW N/A
  • Fundamental
  • Price
  • PNTG $31.81
  • BCTXW $0.30
  • Analyst Decision
  • PNTG Buy
  • BCTXW
  • Analyst Count
  • PNTG 4
  • BCTXW 0
  • Target Price
  • PNTG $37.50
  • BCTXW N/A
  • AVG Volume (30 Days)
  • PNTG 211.3K
  • BCTXW N/A
  • Earning Date
  • PNTG 11-06-2024
  • BCTXW N/A
  • Dividend Yield
  • PNTG N/A
  • BCTXW N/A
  • EPS Growth
  • PNTG 53.90
  • BCTXW N/A
  • EPS
  • PNTG 0.64
  • BCTXW N/A
  • Revenue
  • PNTG $611,806,000.00
  • BCTXW N/A
  • Revenue This Year
  • PNTG $27.15
  • BCTXW N/A
  • Revenue Next Year
  • PNTG $16.03
  • BCTXW N/A
  • P/E Ratio
  • PNTG $50.57
  • BCTXW N/A
  • Revenue Growth
  • PNTG 21.93
  • BCTXW N/A
  • 52 Week Low
  • PNTG $11.56
  • BCTXW N/A
  • 52 Week High
  • PNTG $37.13
  • BCTXW N/A
  • Technical
  • Relative Strength Index (RSI)
  • PNTG 41.08
  • BCTXW N/A
  • Support Level
  • PNTG $31.92
  • BCTXW N/A
  • Resistance Level
  • PNTG $33.19
  • BCTXW N/A
  • Average True Range (ATR)
  • PNTG 1.14
  • BCTXW 0.00
  • MACD
  • PNTG -0.25
  • BCTXW 0.00
  • Stochastic Oscillator
  • PNTG 8.13
  • BCTXW 0.00

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About BCTXW BriaCell Therapeutics Corp. Warrant

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

Share on Social Networks: